MENA Syringes & Cannula Market Size, Trends, Growth, Forecast & Analysis 2032 | UnivDatos

The MENA Syringes & Cannula Market was valued at USD 1,505.79 million in 2023 and is expected to grow at a CAGR of 7.29% during the forecast period (2024-2032)

Market Growth: A growing count of elderly and obese population, global healthcare costs, and a growing incidence of chronic diseases, including diabetes and cardiovascular diseases.

Technological Advancements: The availability of the latest and most advanced syringes, as well as the cannula safety and biocompatibility in the MENA region, helps provide better and safer sterilization and treatment.

Regulatory Landscape: Biopharmaceutical companies in the MENA region experience a diverse regulatory environment as they adapt to the bureaucratic approval procedures of the individual nation states due to the absence of a unified regulatory system.

Market Dynamics: Both international and domestic players sell products that are differentiated based on innovation, quality, and price.

Opportunities and Challenges: Investing in more health facilities, medical tourism, and affiliations with health facilities remain diverse. Nonetheless, threats, including counterfeits, pricing concerns, and health cost inequalities, remain key hurdles for market stakeholders.

Owing to the aging population is more vulnerable to illnesses that require hospitalization and medical procedures that involve syringes and cannula. As per the United Nations Population Fund (UNFPA), in 2024, the United Arab Emirates is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 - 2050 from about 311,000 (3.1% of the total population) to 2 million (19.7%). Adding to this, the increased rate of diabetes, cardiovascular diseases, and other chronic diseases led to other increased frequency of standard medical procedures. Furthermore, the use of devices like cannula for surgeries and treatments has increased as medical procedures have advanced.

The report suggests that Syringes & Cannula resources in the MENA region had a significant impact on the Syringes & Cannula industry in the MENA region. Some of how this impact has been felt include:

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/mena-syringes-cannula-market?popup=report-enquiry

In April 2024: Medline announced it has entered into a definitive agreement to acquire Ecolab, Inc.'s global surgical solutions business, including the industry-leading Microtek product lines. Once closed, the acquisition will provide Medline with innovative sterile drape solutions for surgeons, patients, operating room equipment, and Ecolab’s fluid temperature management system.

In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.

In February 2021, the Advanced Medical Technology Association (AdvaMed) inked a MoU, entering a formal relationship with MECOMED, MEA’s medical devices, imaging, and diagnostics trade association. The collaboration facilitated information sharing between both organizations and increased the ability to strengthen this market.

In May 2021, Medovate, a medical device manufacturer in the U.K., announced a partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country.

Click here to view the Report Description & TOC: https://univdatos.com/reports/mena-syringes-cannula-market

Apart from this, in recent years, UAE has significant growth in MENA, and North Africa has enhanced the growth of the Syringes & Cannula industry:

The UAE is expected to grow with a significant CAGR during the forecast period (2024-2032). The market of syringes and cannula in UAE is consequently driven by government initiatives to enhance healthcare and construct better healthcare facilities. The current government’s investment in health under Vision 2021 has emphasized quality health facilities that depend majorly on medical disposables for the overall safe course of medical practice. For instance, in October 2022, the Ministry of Industry and Advanced Technology (MoIAT) announced the signing of a pair of MoU worth Dh 260 million (USD 7 million) between major pharmaceutical companies and medical devices companies in the United Arab Emirates. The UAE has a well-developed healthcare sector featuring modern hospitals and clinics generating demand for superior medical consumables like syringes and cannula. In addition, the UAE is one of the prominent medical tourism destinations in the region, hosting patients from all corners of the world and adding to the demand for medical devices and supplies.

Conclusion

In conclusion, Syringes & Cannula market in the MENA region is anticipated to show considerable growth in the future due to strategic healthcare investments and increasing incidences of chronic diseases. It was found that technological factors are indeed crucial, of which the move towards safer and more efficient medical device is prominent. However, one of the major issues facing the market players is the operationalization of these diverse regulatory frameworks regarding renewable energy implementation within the different countries of the MENA region. Therefore, in the future, the focus must be on long-term development and marketing, investing in innovation and compliance to capture new opportunities and maintain the scale of competitiveness in this evolving and growing healthcare market.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2024−2032

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis By Product; By Usage; By Distribution Channel

Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Contact Us:

UnivDatos

Email: contact@univdatos.com 

Contact no: +1 978 7330253

Website: www.univdatos.com

Linked In: https://www.linkedin.com/company/univ-datos/